INTRODUCTION
Approximately 4% to 7% of all adults have thyroid nodules. Current epidemiologic data have shown that only 5% to 6.5% of the reported cases of thyroid nodules found by ultrasonography (US) are malignant and require further workup [1] [2] [3] . As the increasing prevalence of thyroid cancer increases, there is a need for a method that can identify malignant lesions that warrant further surgical treatment [4, 5] .
To date, fine needle aspiration (FNA) is not only the traditional diagnostic test for identifying malignant thyroid nodules [6] , but also represents the "gold standard" preoperative test for diagnosing thyroid cancer. However, the sensitivity of FNA ranges from 65% to 98%, and the specificity from 72% to 98% [7] . The Bethesda classification system is typically used for indeterminate cytological results (atypical cells of undetermined significance, follicular ne-thesurgery.or.kr oplasm or suspicion of follicular neoplasm, suspicion of malignancy), which can further complicate the situation.
Consequently, surgical resection is often required in indeterminate cases for a definitive diagnosis. Therefore, a comprehensive diagnostic algorithm using US findings is of interest to ensure accurate diagnosis and therapeutic planning, and to decrease diagnostic operative resections.
Neck US has long been used to evaluate the size, character and location of thyroid nodules, monitor nodule growth, and identify locoregional lymphadenopathy [6, [8] [9] [10] . Many studies have classified specific US characteristics predictive of malignant thyroid nodules. For instance, current US characteristics are that strongly correlated with malignancy include increased intranodular vascularity, the presence of micro-of macrocalcifications, a taller-than-wide pattern, hypoechogenecity, and speculated margins [11, 12] . Although controversial, the current guidelines state that if any one of the above findings is observed, with the exception of increased intranodular vascularity, the nodule should be defined as suspicious for malignancy. In contrast, simple cysts defined as nodules that are predominantly cystic, cystic with comet tail artifacts, or nodules with a spongiform appearance are all likely to be benign. Indeterminate nodules are those that are not characteristic of either malignant or benign [11, 13] .
As the main issue with the current guidelines is the overestimation of malignant and indeterminate nodules, they are not useful in the decision-making process of a treatment plan as they result in unnecessary invasive procedures, including FNA and diagnostic thyroidectomy.
The purpose of this study is to address the disadvantages of the current guidelines by suggesting a new US-based guideline system for thyroid nodules. As well, with the use of these new guidelines, we discuss specific indications for US-guided FNA.
METHODS
Clinical and pathologic data were retrospectively col- Lastly, the malignant category was defined as all histopathology positive for malignancy. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for US characteristics that suspicious for malignant nodules of both current and new guideline. Sensitivity, specificity, accuracy, PPV, and NPV were calculated for both current and new guidelines, with PASW ver. 18.0 (IBM Co., Armonk, NY, USA) used for statistical analysis. (Table 5) .
The relative sensitivity, specificity, PPV, and NPV for the current guidelines in predicting malignancy were 99.3%, 62.2%, 25.0%, and 99.8%, respectively. In comparison, the relative sensitivity, specificity, PPV, and NPV for the new thesurgery.or.kr (Table 6) .
DISCUSSION
To date, there have been several studies that examined specific US characteristics that accurately distinguished malignant from benign thyroid nodules. However, most of this data merely confirms US characteristics associated with malignancy [10, [14] [15] [16] . Thus, studies have suggested developing new US guidelines using data from many cases to resolve this problem. Among the established guidelines; the most widely accepted definition of a lesion causing concern for malignancy if any of the aforementioned characteristics are present. In contrast, a simple cyst, which is predominantly a cystic lesion or a cystic nodule with comet tail artifacts, or a nodule with a spongiform appearance are characterized as probably benign. Indeterminate nodules include lesions with US findings that are known to be neither malignant nor benign. However, these particular guidelines are controversial as they tend to overestimate malignant and indeterminate nodules.
Cooper et al. [17] reported that with the exception of suspi- However, this classification system is difficult to apply clinically due to its marked complexity [19] . Therefore, the intention to develop a more accurate, and simple guideline for thyroid nodules was explored.
Frates et al. [14] reported a range of sensitivity, specificity, PPV, and NPV of US characteristics suggested for malignancy by current guideline.
Sensitivity, specificity, PPV, and NPV of US characteristics suggesting malignancy by the current guidelines in this study was similar to that. Especially, sensitivity of marked hypoechogenecity is the highest. Generally, the new guidelines had better specificity and PPV than the current guidelines. Even though the current guidelines were more sensitive than the new guidelines. It seems to be the cause of lower sensitivity of the new guidelines than the current guidelines.
The results showed that the new guidelines had better accuracy, specificity, and PPV than the current guidelines, although the NPV was not significantly different between the two. Even though the current guideline system was more sensitive than the new guidelines, the new guidelines allowed for better diagnostic accuracy and proper well-defined, taller-than-wide, and isoechoic with peripheral hypoechoic halos (Fig. 1) , and three cases where the lesions were well-defined, oval-shaped, and markedly hypoechoic (Fig. 2) . Together, these six nodules were diag- we recommend the lesion be followed by US (Fig. 3) . These new FNA guidelines help avoid unnecessary FNAs and promote a cost-effective follow-up for patients.
In conclusion, the use of the new US guidelines allow for greater accuracy with higher specificity for diagnosis and treatment planning than the current guidelines.
Additionally, the use of the new FNA guidelines based on the new US guidelines help avoid unnecessary FNAs and promotes cost-effective follow-up for patients.
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